L. Bêta, AVONEX®) est un des principaux traitements de la sclérose en plaque Ce médicament permet de réduire la fréquence des poussées et ralentit la progression du handicap. Afin d'améliorer l'observance, Inhale et Biogen (113) se sont associés dans le but de développer une version inhalable de ce traitement : pour le moment, Beta~la

. Pivalone-endosinus, ® (tixocortol+néomycine): 1 flacon/jour Mucomyst lg/5ml (Acétylcysteine): 1 ampoule par jour +Un embout nasal QSP 12 jours

A. T. , U. J. Zhou-m, and . Campo-c, Inhibition of allergie late airway responses by inhaled heparin-derived oligosaccharides, J Appl Physiol, vol.88, pp.1721-1729, 2000.

A. M. Moss-rb, W. Al, and T. D. , A phase I study of aerosolized administration oftgAA VCF to cystic fibrosis subjects with mild lung disease, Hum Gene Ther, issue.15, pp.121907-1916, 2001.

A. Ton, E. W. , S. M. , and F. R. Arley, Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial, Lancet, issue.9157, pp.353947-954, 1999.

A. P. Markovic-s and S. J. , Aerosol Granulocyte Macrophge-Colony Stimulating Factor : A low toxicity , lung specific biological therapy in patient with lung metastases, Clin Cancer Res, vol.5, issue.9, pp.2316-2323, 1999.

A. K. Ferdoutsis-a and B. D. , Interferons and their application in the disease of th lung, Chest, vol.123, issue.1, pp.209-216, 2003.

B. Chorf and A. Gardan-b, La mucoviscidose, Cahier formation continue, le moniteur des pharmacies et des laboratoires, 2000.

B. G. Michel-calemard and T. D. , Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: a phase I clinical trial. Hum, Gene Ther, vol.8, issue.1, pp.15-25, 1997.

B. K. Chambers-c, J. J. , and N. M. , Lung deposition and clearance of inhaled (99m)Tc-heparin in healthy volunteers, Am. J. Respir. Crit. Care Med, issue.5, pp.1601653-1658, 1999.

B. S. , R. M. Vaghi-a, and P. M. Sestini-p, Protective effect of inhaled piretanide on the bronchial obstructive response to ultrasonically nebulized H20. A dose-response study, Chest, vol.104, issue.1, pp.185-188, 1993.

B. F. and R. G. Pfeifer-m, Hemodynamic effects ofaerosolized iloprost in pulmonary hypertension at rest and during exercise, Chest, issue.5, pp.1211566-1571, 2002.

C. S. Kingston-hd and . Stern-m, Safety of a single aerosol administration of escalating doses of the cationic lipid GL-67/DOPE/DMPE-PEG5000 fonnulation to the lungs of normal volunteers, Gene Ther, issue.49, pp.937-942, 1997.

C. X. and L. J. Zhou-t, The effects of interleukin-12 inhalation on airway inflammation and T helper cell subsets in mouse asthma models, Zhonghua Nei Ke Za Zhi, issue.5, pp.41313-316, 2002.

C. R. and R. W. Schluger-n, Treatment ofmultidmg resistant pulmonary tuberculosis with interferon gamma via aerosol, Lancet, issue.9064, pp.3491513-1515, 1997.

C. N. Prosperini-g, C. I. Mastruzzo-c, and . Magri-s, Changes in neurokinin A (NKA) airway responsiveness with inhaled fmsemide in asthma

D. M. and W. J. Morishige-r, Phannacokinetics and pharmacodynamies of inhaled versus intravenous morphine in healthy volunteers, Anesthesiology, issue.3, pp.93-619, 2000.

D. P. , F. F. Aurisson, . Huet-f, and . Pin-i, SAUTEGEAU A Des médicaments dans les nuages, livret destiné aux patients et à leurs parents. Association Française de Lutte contre la Mucoviscidose

D. M. Rusch-p and . Granjon-d, Preliminary study of the deposition of aerosol in the maxillary sinuses using a plastinated model, JAM, vol.14, issue.1, pp.83-93, 2001.

G. Delamare, Dictionnaire des termes de médecine ,25ème édition, Edition Maloine, 1998.

G. Ha and R. F. Wiedemann-r, Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension, Ann Intern Med, issue.7, pp.136515-522, 2002.

G. D. Southern-k and M. K. , A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis, Gene Ther, issue.43, pp.199-209, 1997.

G. S. and C. M. Alemanno-l, Effects of aerosolized interferon alpha in patients with pulmonary tuberculosis, Am. J. Respir. Crit. Care Med, vol.158, issue.4, pp.1156-1162, 1998.

G. S. and C. M. Ameglio-f, Aerosolized interferon-alpha treatment in patients with multi-drug-resistant puhnonary tuberculosis, Eur. Cytokine Netw, vol.11, issue.1, pp.99-104, 2000.

G. M. , L. P. , Y. J. Wilson, and J. M. , Lentiviral vectors for gene therapy of cystic fibrosis. Hum, Gene Ther, issue.18, pp.82261-2268, 1997.

P. .. Ache-m and D. A. Belisle-s, Inhaled prostacyclin (PGI2) is an effective addition to the treatment of pulmonary hypertension and hypoxia in the operating room and intensive care unit, Can J Anaesth, issue.9, pp.48-924, 2001.

H. J. , M. R. , A. M. Lange-c, M. H. , W. H. et al., Anticoagulant effects and tissue factor pathway inhibitor after intrapulmonary low-molecular-weight heparin, Blood Coagul Fibrinolysis, vol.7, issue.4, pp.477-483, 1996.

H. Jb, lnhaled furosemide in the treatment of acute exacerbations of asthma

H. M. , G. C. , and G. J. Rw, Randomised UK/Eire clinical trial of the efiicacy and safety of tobramycin 300mg/5ml nebuliser solution or nebulized colistin in CF patients, European Cystic Fibrosis Conference, pp.4-8, 2000.

H. M. and P. A. Batten-j, Aerosol carbenicillin and gentamicin treatment of pseudomonas aeroginosa infection in patient with cystic fibrosis, Lancet, issue.28256, pp.1137-1139, 1981.

H. M. Schw and E. S. , Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue, N Engl J Med, issue.25, pp.3421866-1870, 2000.

H. E. , H. H. Mir-t, and . Huland-h, Inhaled interleukin-2 therapy in pulmonary metastatic renal cell carcinoma: six years of experience, Cancer J. Sei. Am, issue.3, pp.98-105, 1997.

H. S. Southern-k and . Gileadi-u, Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis, Gene Ther, issue.13, pp.71156-1165, 2000.

I. Amoto-lm, G. Dm, and N. Kt, Loop Diuretics and In Vitro Relaxation of Human Fetal and Newborn Mouse Airways, Pediatric Research, vol.273, issue.2, pp.273-276, 2001.
DOI : 10.1203/00006450-200108000-00018

J. L. , M. J. Kav, and A. L. , Intrapulmonary heparin.A new procedure for anticoagulant therapy, Lancet, issue.27996, pp.1157-1161, 1976.

K. R. Iacono-a and D. J. , Treatment ofrefractory acute allograft rejection with aerosolized cyclosporine in lung transplant recipients, J Thor Cardiovasc Surg, vol.113, issue.2, pp.335-340, 1997.

K. A. and D. M. Garg-m, Pulmonary effect ofinhaled furosemide in ventilated infants with severe bronchopulmonary dysplasia, Pediatrics, vol.99, issue.1, pp.71-75, 1997.

L. M. , G. M. , H. C. , and W. Alsha-w-m, Nebulized heparin in burkholderia cepacia colonized adult cystic fibrosis patients, Eur Respir J, vol.17, issue.1, pp.36-38, 2001.

L. M. , A. Ds, F. M. , and P. Dw, Recovery of airway cystic fibrosis transmembrane conductance regulator fonction in mice with cystic fibrosis after single-dose lentivims-mediated gene transfer, Hum Gene Ther, issue.16, pp.131961-1970, 2002.

M. J. Diot-p, Voie inhalée pour l'administration de médicaments a visée systémique, Rev. Mal. Respir, vol.14, pp.256-267, 1997.

M. J. Salin-d, La Mécanique des Fluides, 1997.

M. L. , W. A. , W. M. Parr-s, . Rubsamen-ra, and . G. Eltherington-l, Pulmonary administration of aerosolised fentanyl: phannacokinetic analysis of systemic delivery, Br J Clin Pharmacol, issue.1, pp.4637-4680, 1998.

M. H. Shimizu-t and M. A. , Inhaled diuretics attenuate Acid-induced cought in children with asthma, Chest, vol.107, issue.2, pp.413-717, 1995.

M. Jf, C. C. , S. S. , and A. T. , Inhibition ofantigen-induced airway hyperresponsiveness by ultralow molecular-weight heparin, Am. J. Respir. Crit. Care Med, issue.3, pp.157887-93, 1998.

N. E. Frongia-g, R. M. Lombard-!-e, . Zammarchi-e, and . Vierucci-a, The preventive effects and duration of action of two doses of inhaled furosemîde on exercise-induced asthma in children, J. Allergy Clin. Immunol, issue.6, pp.96-906, 1995.

C. B. Yeo-c, . M. Chen-worsdell-y, and C. J. Barnes-p, Effect of acetazolamide and amiloride against sodium metabisulphite-induced bronchoconstriction in mild asthma, Thorax, issue.11, pp.49-1096, 1994.

O. H. Simmonneau-g and . Galien, Inhaled iloprost for pulmonary hypertension, N Engl J Med, vol.347, issue.5, pp.322-329, 2002.

P. G. Marchand-m and . Foucaud-c, French multicenter randomized double-blind placebo-con-trolled trial on nebulized amiloride in cystic fibrosis patients, Pediatr. Pulmonol, issue.1, pp.30-55, 2000.

R. , A. C. , S. J. Lombard-!-d, and . A. Molfino-n, Treatment of acute severe asthma with inhaled albuterol delivered via jet nebulizer, metered dose inhaler with spacer, or dry powder, Chest, vol.112, pp.24-28, 1997.

R. B. Dorkin-h and E. J. , Efficacy of aersolised tobramycin in patients infected with cystic fibrosis, N engl J med, vol.328, pp.1740-1746, 1993.

R. B. and P. M. Quan-j, Intermittent administration ofinhaled tobramycin in patients with cystic fibrosis, N ENgl J Med, vol.34, issue.1, pp.23-30, 1999.

R. J. Hutteger-i, Pilot study of amiloride inhalation in children with cystic fibrosis, Klin Padiatr, vol.204, issue.3, pp.158-162, 1992.

R. S. and C. F. Harding-n, Phannacokinetics, pharmacodynamies, and safety of inhaled cyclosporin A (ADI628) after single and repeated administration in healthy male and female subjects and asthmatic patients, J Clin Phannacol, issue.11, pp.40-1211, 2000.

S. S. Brochard-l and M. H. , Nebulized versus intravenous albuterol in hypercapnie acute asthma. A multicentem double-blind , randomized study, Am J Resp Crit Care Med, vol.149, pp.1466-1470, 1994.

S. J. , C. W. , K. I. Et, and . Al, Efficacy ofinhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study, Lancet, vol.357, issue.9253, pp.331-335, 2001.

S. R. Hodson-m and . C. Batten-j, Inhaled ceftazidime compared with gentamicin and carbenicillin in older patients with cystic fibrosis infected with psudomonas aeroginosa, Br J DIS Chest, vol.81, pp.272-279, 1987.

S. R. Freed and . An, Heparin inhibits eicosanoid metabolism and hyperventilationinduced bronchoconstriction in Dogs, Am. J. Respir. Crit. Care Med, issue.6, pp.161-1850, 2000.

S. R. Freed and . An, Heparin Inhibits Hyperventilation-Induced Late-Phase Hyperreactivity in Dogs, Am. J. Respir. Crit. Care Med, vol.165, issue.1, pp.27-33, 2002.

T. R. , A. P. Zein-n, . Temesgen-z, W. M. Cla, and . Weiss-w, Interleukin-2 liposomes for primary immune deficiency using the aerosol route, Int. Immunopharmacol, vol.2, issue.2-3, pp.333-344, 2002.

T. G. Grabowski-s, Principes d'anatomie et de physiologie, deuxieme édition française

W. D. Th, . Schneider-t, . Schermul-y-r, . Olschewski-h, . Grimminger-f et al., Direct comparison ofinhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome, Am J Respir Crit Care Med, issue.3, pp.153991-996, 1996.

W. M. Woodhouse-a and M. L. , Morphine pharmacokinetics after pulmonary administration from a novel aerosol delivery system, Clin Pharmacol Ther, issue.6, pp.62-596, 1997.

X. Q. , C. J. Shen-w, and Y. Q. Bian-r, Effects of cyclosporin A by aerosol on airway hyperresponsiveness and inflammation in guinea pigs, Acta Pharmacol Sin, vol.23, issue.3, pp.243-250, 2002.

Y. I. Daviskas-e and K. A. Eena-v, Effect oflow dose nebulised morphine on exercise endurance in patients with chronic lung disease, Thorax, issue.5, pp.44387-390, 1989.

Z. J. Cheng-s, . Meek, and . D. Er, Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo, J. Clin. Invest, issue.6, pp.100-1529, 1997.

. Anonymes, L'aérosolthérapie par nébulisation. Cahier de pharmacothérapie, Actualité Phannaceutique, 2000.